retro biosciences

6+ articles

AGI Development AI AI and Longevity AI competition AI in medicine

Tech Moguls Bankrolling the Race Against Time: Can Cash Combat Aging?

The article from Business Insider delves into the burgeoning scene of tech billionaires heavily investing in biotechnology aimed at extending human lifespans. These big-name investors, including Sam Altman, Jeff Bezos, and Sergey Brin, are backing innovative startups like Retro Biosciences, focused on anti-aging technologies. The piece explores not only the motivations behind these investments but also the ethical, economic, and social implications of potentially lengthening human life.

Sep 14

Tech Moguls Bankrolling the Race Against Time: Can Cash Combat Aging?

Massive January 2025 Investment Wave: Infinite Reality and Anthropic Lead the Charge

January 2025 witnessed a tremendous surge in investment, with Infinite Reality and Anthropic leading notable funding rounds. Infinite Reality snagged a colossal $3 billion for augmented reality development, while Anthropic secured $1 billion to enhance AI capabilities. These substantial investments indicate a robust trust in technology-driven innovation, drawing attention to diverse sectors including biotech, energy, and e-commerce.

Feb 4

Massive January 2025 Investment Wave: Infinite Reality and Anthropic Lead the Charge

OpenAI Announces o3 Mini: Pioneering Future of AI with Advanced Reasoning!

OpenAI has revealed plans to launch its groundbreaking o3 mini AI model in early 2025, tailored to tackle complex tasks in sciences, mathematics, and coding. In collaboration with Retro Biosciences, OpenAI aims to push the boundaries of longevity science with GPT-4b micro focusing on protein re-engineering for regenerative medicine.

Jan 20

OpenAI Announces o3 Mini: Pioneering Future of AI with Advanced Reasoning!

OpenAI & Retro Biosciences' GPT-4b: AI Takes a Leap Towards Extending Human Lifespan!

In an exciting collaboration, OpenAI and Retro Biosciences unveil GPT-4b, an advanced AI model revolutionizing protein engineering and cellular reprogramming. The model showcases a staggering 50x enhancement in Yamanaka factors' effectiveness, promising to extend human lifespan by 10 years. With backing from Sam Altman and featuring cutting-edge AI technology, this breakthrough poses significant implications for regenerative medicine and the path towards AGI.

Jan 18

OpenAI & Retro Biosciences' GPT-4b: AI Takes a Leap Towards Extending Human Lifespan!

OpenAI and Retro Biosciences: A Bold Leap in Longevity with AI-Powered Protein Re-engineering!

OpenAI teams up with Retro Biosciences to push the boundaries of human longevity! Leveraging AI technology, they create GPT-4b micro, a unique model focusing on re-engineering Yamanaka factors to transform skin cells into stem cells. Could this collaborative breakthrough in regenerative medicine pave the way for organ creation and extend our lifespans by an extra 10 years?

Jan 18

OpenAI and Retro Biosciences: A Bold Leap in Longevity with AI-Powered Protein Re-engineering!

OpenAI & Retro Biosciences Leap Into the Future with GPT-4b

OpenAI and Retro Biosciences have teamed up to create GPT-4b, an AI model that's changing the game in bioengineering. Instead of focusing on protein structures, GPT-4b specializes in protein interactions, showing promise in enhancing Yamanaka factors. This groundbreaking collaboration could transform stem cell treatments and regenerative medicine, offering new hope for various medical conditions.

Jan 18

OpenAI & Retro Biosciences Leap Into the Future with GPT-4b